MedTrace Logo

The Efficacy β-Alanine Supplementation in Performance Outcomes of Road Professional Endurance Cyclists

NCT04427319 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2020-07-30

No results posted yet for this study

Summary

A double-blind, placebo-controlled, randomised, with two arms (product and placebo) unicentric clinical trial to analyse the efficacy on physical performance parameters of a product designed for sport during a lapse of two weeks (7 days).

Conditions

  • Supplementation
  • Cyclists

Interventions

DIETARY_SUPPLEMENT

β-alanine

7 days of consumption

DIETARY_SUPPLEMENT

wheat semolina

7 days of consumption

Sponsors & Collaborators

  • Universidad Católica San Antonio de Murcia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-10
Primary Completion
2020-03-06
Completion
2020-06-12

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04427319 on ClinicalTrials.gov